No recent analyst price targets found for REUN.
Latest News for REUN
Reunion Neuroscience to Present Full Data from RECONNECT Phase 2 Clinical Trial at Upcoming ASCP and APA Annual Meetings
MORRISTOWN, N.J., May 11, 2026 (GLOBE NEWSWIRE) -- Reunion Neuroscience, Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health disorders through the advancement of next-generation psychedelic-inspired therapeutic solutions, today announced that it will share the full results of the RECONNECT, a Phase 2 trial evaluating luvesilocin in adult female…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for REUN.
Senate Trading
No Senate trades found for REUN.
U.S. House Trading
No House trades found for REUN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.